Free Online CME

How to Obtain AMA PRA Category 1 Credit

  1. Read the CME Monograph.
  2. Log into your myCME account.
  3. Complete the credit and evaluation form.
  4. Print your personalized CME certificate.

Technical Requirements

Advances in Biologic Therapies

State of the Art of Autoimmune and Autoinflammatory, Immunodeficiency Diseases Monograph: Immunotherapy - Good for Cancer, Bad for Autoimmunity

Print this Content

Release Date: August 9, 2016
Expiration Date: August 9, 2018

Estimated Time of Completion: 30 minutes

Description

The State of the Art of Autoimmune and Autoinflammatory, Immunodeficiency Diseases Monograph: Immunotherapy - Good for Cancer, Bad for Autoimmunity summarizes the Interactive Cases: Challenges in Clinical Immunology (Autoimmune, Autoinflammatory, Immunodeficiency Diseases) presented during the 4th Annual Basic and Clinical Immunology Symposium.

Learning Objectives

  1. Describe the mechanism of action (MOA) of immunotherapy in cancer.
  2. Relate MOA to the pathophysiology of 'immune-related adverse events' (irAEs).
  3. Recognize, diagnose and manage the rheumatologic irAEs.

Target Audience

This activity is directed to rheumatologists, dermatologists, allergists, infectious disease practitioners, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Cassandra Calabrese, DO
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his contribution, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
  GSK; Pfizer, Inc.; Sanofi Aventis; UCB Consulting
  Abbvie; Bristol-Myers Squibb Co.; Genentech/Roche; Janssen Consulting; Teaching and Speaking
  Cresecendo Bioscience, Inc. Teaching and Speaking

The following faculty has indicated that she has no relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:

Cassandra Calabrese, DO

The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Exagen Diagnostics
Genentech, Inc.
Pfizer, Inc.

This CME activity was produced by the Cleveland Clinic Center for Continuing Education and Cleveland Clinic's R.J. Fasenmyer Center for Clinical Immunology.